Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.

Identifieur interne : 000091 ( Main/Exploration ); précédent : 000090; suivant : 000092

Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.

Auteurs : Patrick Saunders-Hastings [Canada] ; Bryson Quinn Hayes [Canada] ; Robert Smith [Canada] ; Daniel Krewski [Canada]

Source :

RBID : pubmed:28614365

Descripteurs français

English descriptors

Abstract

BACKGROUND

A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur.

METHODS

We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions.

RESULTS

There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented.

DISCUSSION

Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However-given the inherent uncertainties of model assumptions-results should be interpreted with caution.


DOI: 10.1371/journal.pone.0179315
PubMed: 28614365


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.</title>
<author>
<name sortKey="Saunders Hastings, Patrick" sort="Saunders Hastings, Patrick" uniqKey="Saunders Hastings P" first="Patrick" last="Saunders-Hastings">Patrick Saunders-Hastings</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Quinn Hayes, Bryson" sort="Quinn Hayes, Bryson" uniqKey="Quinn Hayes B" first="Bryson" last="Quinn Hayes">Bryson Quinn Hayes</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, Department of Mathematics, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smith, Robert" sort="Smith, Robert" uniqKey="Smith R" first="Robert" last="Smith">Robert Smith</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, Department of Mathematics, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Krewski, Daniel" sort="Krewski, Daniel" uniqKey="Krewski D" first="Daniel" last="Krewski">Daniel Krewski</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28614365</idno>
<idno type="pmid">28614365</idno>
<idno type="doi">10.1371/journal.pone.0179315</idno>
<idno type="wicri:Area/Main/Corpus">000088</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000088</idno>
<idno type="wicri:Area/Main/Curation">000088</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000088</idno>
<idno type="wicri:Area/Main/Exploration">000088</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.</title>
<author>
<name sortKey="Saunders Hastings, Patrick" sort="Saunders Hastings, Patrick" uniqKey="Saunders Hastings P" first="Patrick" last="Saunders-Hastings">Patrick Saunders-Hastings</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Quinn Hayes, Bryson" sort="Quinn Hayes, Bryson" uniqKey="Quinn Hayes B" first="Bryson" last="Quinn Hayes">Bryson Quinn Hayes</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, Department of Mathematics, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smith, Robert" sort="Smith, Robert" uniqKey="Smith R" first="Robert" last="Smith">Robert Smith</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, Department of Mathematics, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Krewski, Daniel" sort="Krewski, Daniel" uniqKey="Krewski D" first="Daniel" last="Krewski">Daniel Krewski</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Algorithms</term>
<term>Canada (epidemiology)</term>
<term>Forecasting</term>
<term>Health Resources (statistics & numerical data)</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Hospitalization (trends)</term>
<term>Hospitals (statistics & numerical data)</term>
<term>Humans</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (transmission)</term>
<term>Models, Theoretical</term>
<term>Pandemics (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Algorithmes</term>
<term>Canada (épidémiologie)</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation ()</term>
<term>Hospitalisation (tendances)</term>
<term>Humains</term>
<term>Hôpitaux ()</term>
<term>Modèles théoriques</term>
<term>Pandémies ()</term>
<term>Prévision</term>
<term>Ressources en santé ()</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Canada</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Health Resources</term>
<term>Hospitalization</term>
<term>Hospitals</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr">
<term>Hospitalisation</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Hospitalization</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Canada</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Algorithms</term>
<term>Forecasting</term>
<term>Humans</term>
<term>Models, Theoretical</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Algorithmes</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Hôpitaux</term>
<term>Modèles théoriques</term>
<term>Pandémies</term>
<term>Prévision</term>
<term>Ressources en santé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DISCUSSION</b>
</p>
<p>Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However-given the inherent uncertainties of model assumptions-results should be interpreted with caution.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28614365</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>12</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.</ArticleTitle>
<Pagination>
<MedlinePgn>e0179315</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0179315</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented.</AbstractText>
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However-given the inherent uncertainties of model assumptions-results should be interpreted with caution.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saunders-Hastings</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-3602-0842</Identifier>
<AffiliationInfo>
<Affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quinn Hayes</LastName>
<ForeName>Bryson</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-1903-592X</Identifier>
<AffiliationInfo>
<Affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krewski</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>06</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006295" MajorTopicYN="N">Health Resources</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>01</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>05</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28614365</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0179315</ArticleId>
<ArticleId IdType="pii">PONE-D-17-02554</ArticleId>
<ArticleId IdType="pmc">PMC5470707</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1316-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23560537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Pharmacother. 2000 May;54(4):188-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10872717</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Microbiol. 2001 Oct;91(4):572-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11576290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jul;34(7):509-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22041776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2011 Feb 25;11 Suppl 1:S1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21356128</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001169</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16625539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Math Biosci. 2002 Nov-Dec;180:29-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12387915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2009 Dec 24;9:488</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20034405</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prev Med. 2012 Jun;54(6):434-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22548868</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Oct 30;326(5953):729-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2009 Sep 15;170(6):679-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19679750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22032844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2007 Apr;135(3):372-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16928287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2005 Aug;3(8):591-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16064053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Biol Sci. 2011 Sep 22;278(1719):2753-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21288945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosecur Bioterror. 2009 Sep;7(3):265-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19656012</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19433588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2004 Dec 16;432(7019):904-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15602562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2010 Feb 9;182(2):131-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19959592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2011 Jan 03;11:2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21199571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathogens. 2016 Dec 06;5(4):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27929449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Control Hosp Epidemiol. 2011 Dec;32(12):1149-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22080652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2013 Nov;10(11):e1001558</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24302890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18685555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2015 Oct;89(19):9920-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26202246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2011 Mar;50(3):235-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21195022</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Aug 28;371(9):796-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25162885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Themes Epidemiol. 2013 May 07;10(1):3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23651557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 May 2;30(21):3209-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22387221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2008 Dec 15;168(12):1343-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18974084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18332436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2012 Sep;6(5):313-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22151080</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 May;7(3):466-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23078163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10877456</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2015 Sep 7;380:60-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25981631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2010 Apr 06;7(4):e1000256</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20386727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Epidemiol. 1994 Aug;10(4):471-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7843359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Aug 12;309(5737):1083-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16079251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2006 Jul 21;241(2):193-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16387331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Environ Res Public Health. 2015 Aug 18;12(8):9750-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26295248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Jun 21;8(6):e67253</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23805303</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phys Life Rev. 2016 Sep;18:66-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27451336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Dec;85(24):13432-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21976646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2007 Jan 18;445(7125):237</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17230157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2010 Jan 29;6(1):e1000656</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20126529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Value Health. 2009 Mar-Apr;12(2):226-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18671770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2014 Apr 10;(4):CD008965</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24718923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2014 Sep 18;14:509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25234544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Biol Sci. 2007 Feb 22;274(1609):599-604</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17476782</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Infect Control. 2010 Jun;38(5):374-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20569849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2011 May 15;173(10):1121-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21427173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S168-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21342890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Intern Med. 1998 Oct;13(10):716-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9798822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2008 Jul 7;253(1):118-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18402981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2006 Jun 22;3(8):453-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16849273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2009 Jun 22;7:30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19545404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Nov 27;8(11):e80481</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24312225</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2009 Nov 10;181(10):673-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19825923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2013 Mar 08;13:211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23496898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2009 Aug 12;9:129</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19674455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Dec;44(12):1075-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21215106</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2015 Jun 09;15:543</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26055522</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 May;7(3):418-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22804954</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 May 06;5(5):e10520</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20463898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hosp Infect. 2010 Mar;74(3):271-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20061056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Theor Biol Med Model. 2006 Nov 30;3:38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17137517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Aug 31;28(38):6210-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20643091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Jan 15;50(2):165-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20021259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Value Health. 2012 Sep-Oct;15(6):982-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22999151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2009 Oct 6;151(7):464-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19652173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2012 Jan 26;12:26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22280120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5935-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16585506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2010 Apr 19;10:99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20403201</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2007 Apr;13(4):581-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17553273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2006 Nov 10;24(44-46):6701-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16806596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Math Biosci Eng. 2013 Oct-Dec;10(5-6):1475-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24245626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):799-808</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23122189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2007 Apr 15;44(8):1084-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17366454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Math Biosci. 2006 Oct;203(2):301-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16540129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Cell. 2010 Jan;1(1):9-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21203993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2012 Sep;12(9):687-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22738893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20689501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2004 Apr 1;159(7):623-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15033640</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Saunders Hastings, Patrick" sort="Saunders Hastings, Patrick" uniqKey="Saunders Hastings P" first="Patrick" last="Saunders-Hastings">Patrick Saunders-Hastings</name>
</noRegion>
<name sortKey="Krewski, Daniel" sort="Krewski, Daniel" uniqKey="Krewski D" first="Daniel" last="Krewski">Daniel Krewski</name>
<name sortKey="Krewski, Daniel" sort="Krewski, Daniel" uniqKey="Krewski D" first="Daniel" last="Krewski">Daniel Krewski</name>
<name sortKey="Quinn Hayes, Bryson" sort="Quinn Hayes, Bryson" uniqKey="Quinn Hayes B" first="Bryson" last="Quinn Hayes">Bryson Quinn Hayes</name>
<name sortKey="Saunders Hastings, Patrick" sort="Saunders Hastings, Patrick" uniqKey="Saunders Hastings P" first="Patrick" last="Saunders-Hastings">Patrick Saunders-Hastings</name>
<name sortKey="Smith, Robert" sort="Smith, Robert" uniqKey="Smith R" first="Robert" last="Smith">Robert Smith</name>
<name sortKey="Smith, Robert" sort="Smith, Robert" uniqKey="Smith R" first="Robert" last="Smith">Robert Smith</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000091 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000091 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28614365
   |texte=   Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28614365" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020